241 related articles for article (PubMed ID: 28415045)
1. Knockdown of PEBP4 suppresses proliferation, migration and invasion of human breast cancer cells.
Wang SC; Zhou F; Zhou ZY; Hu Z; Chang L; Ma MD
Biomed Pharmacother; 2017 Jun; 90():659-664. PubMed ID: 28415045
[TBL] [Abstract][Full Text] [Related]
2. Phosphatidylethanolamine-binding protein 4 promotes the epithelial-to-mesenchymal transition in non-small cell lung cancer cells by activating the sonic hedgehog signaling pathway.
Jian W; Bai Y; Li X; Kang J; Lei Y; Xue Y
J Cell Biochem; 2019 Apr; 120(4):5386-5395. PubMed ID: 30367510
[TBL] [Abstract][Full Text] [Related]
3. PEBP4 silencing inhibits hypoxia-induced epithelial-to-mesenchymal transition in prostate cancer cells.
Li W; Dong Y; Zhang B; Kang Y; Yang X; Wang H
Biomed Pharmacother; 2016 Jul; 81():1-6. PubMed ID: 27261570
[TBL] [Abstract][Full Text] [Related]
4. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer.
Yan LX; Liu YH; Xiang JW; Wu QN; Xu LB; Luo XL; Zhu XL; Liu C; Xu FP; Luo DL; Mei P; Xu J; Zhang KP; Chen J
Int J Oncol; 2016 Feb; 48(2):471-84. PubMed ID: 26676464
[TBL] [Abstract][Full Text] [Related]
5. Role of the PEBP4 protein in the development and metastasis of gastric cancer.
Wu Z; Liu B; Zheng X; Hou H; Li Y
Oncotarget; 2017 Mar; 8(11):18177-18184. PubMed ID: 28193908
[TBL] [Abstract][Full Text] [Related]
6. FYN promotes breast cancer progression through epithelial-mesenchymal transition.
Xie YG; Yu Y; Hou LK; Wang X; Zhang B; Cao XC
Oncol Rep; 2016 Aug; 36(2):1000-6. PubMed ID: 27349276
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of TRIM47 inhibits breast cancer tumorigenesis and progression through the inactivation of PI3K/Akt pathway.
Wang Y; Liu C; Xie Z; Lu H
Chem Biol Interact; 2020 Feb; 317():108960. PubMed ID: 31981573
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of SLC34A2 Inhibits Hepatocellular Carcinoma Cell Proliferation and Invasion.
Li Y; Chen X; Lu H
Oncol Res; 2016 Oct; 24(6):511-519. PubMed ID: 28281971
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of SPOCK1 Inhibits the Proliferation and Invasion in Colorectal Cancer Cells by Suppressing the PI3K/Akt Pathway.
Zhao P; Guan HT; Dai ZJ; Ma YG; Liu XX; Wang XJ
Oncol Res; 2016 Oct; 24(6):437-445. PubMed ID: 28281964
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of microRNA-190 inhibits migration, invasion, epithelial-mesenchymal transition, and angiogenesis through suppression of protein kinase B-extracellular signal-regulated kinase signaling pathway via binding to stanniocalicin 2 in breast cancer.
Sun G; Liu M; Han H
J Cell Physiol; 2019 Aug; 234(10):17824-17838. PubMed ID: 30993707
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of JARID2 inhibits the proliferation and invasion of ovarian cancer through the PI3K/Akt signaling pathway.
Cao J; Li H; Liu G; Han S; Xu P
Mol Med Rep; 2017 Sep; 16(3):3600-3605. PubMed ID: 28765957
[TBL] [Abstract][Full Text] [Related]
12. FAT4 regulates the EMT and autophagy in colorectal cancer cells in part via the PI3K-AKT signaling axis.
Wei R; Xiao Y; Song Y; Yuan H; Luo J; Xu W
J Exp Clin Cancer Res; 2019 Mar; 38(1):112. PubMed ID: 30832706
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of TRIM37 suppresses the proliferation, migration and invasion of glioma cells through the inactivation of PI3K/Akt signaling pathway.
Tang SL; Gao YL; Wen-Zhong H
Biomed Pharmacother; 2018 Mar; 99():59-64. PubMed ID: 29324313
[TBL] [Abstract][Full Text] [Related]
14. SMAD2 Inactivation Inhibits CLDN6 Methylation to Suppress Migration and Invasion of Breast Cancer Cells.
Lu Y; Wang L; Li H; Li Y; Ruan Y; Lin D; Yang M; Jin X; Guo Y; Zhang X; Quan C
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28867761
[TBL] [Abstract][Full Text] [Related]
15. Small nucleolar RNA ACA11 promotes proliferation, migration and invasion in hepatocellular carcinoma by targeting the PI3K/AKT signaling pathway.
Wu L; Zheng J; Chen P; Liu Q; Yuan Y
Biomed Pharmacother; 2017 Jun; 90():705-712. PubMed ID: 28419966
[TBL] [Abstract][Full Text] [Related]
16. miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.
Xue Y; Xu W; Zhao W; Wang W; Zhang D; Wu P
Biomed Pharmacother; 2017 Feb; 86():426-433. PubMed ID: 28012397
[TBL] [Abstract][Full Text] [Related]
17. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
[TBL] [Abstract][Full Text] [Related]
18. SIN1 promotes the proliferation and migration of breast cancer cells by Akt activation.
Wang D; Wu P; Wang H; Zhu L; Zhao W; Lu Y
Biosci Rep; 2016 Dec; 36(6):. PubMed ID: 27780891
[TBL] [Abstract][Full Text] [Related]
19. Anthrax toxin receptor 1/tumor endothelial marker 8 promotes gastric cancer progression through activation of the PI3K/AKT/mTOR signaling pathway.
Cai C; Dang W; Liu S; Huang L; Li Y; Li G; Yan S; Jiang C; Song X; Hu Y; Gu J
Cancer Sci; 2020 Apr; 111(4):1132-1145. PubMed ID: 31977138
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of TMEM45B inhibits cell proliferation and invasion in gastric cancer.
Shen K; Yu W; Yu Y; Liu X; Cui X
Biomed Pharmacother; 2018 Aug; 104():576-581. PubMed ID: 29803169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
